• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

G 蛋白偶联受体 30 通过减少血管紧张素 II 处理的小鼠中的氧化应激和细胞凋亡来减轻心肌肥厚。

G-protein coupled receptor 30 attenuates myocardial hypertrophy by reducing oxidative stress and apoptosis in Ang II-treated mice.

机构信息

Department of Cardiology, Gaochun People's Hospital, Nanjing, China.

Department of Emergency, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

出版信息

Peptides. 2022 Nov;157:170878. doi: 10.1016/j.peptides.2022.170878. Epub 2022 Sep 13.

DOI:10.1016/j.peptides.2022.170878
PMID:36108979
Abstract

G protein-coupled receptors (GPCRs) are the largest family of membrane receptors that mediate the effects of cardiac diseases. GPR30, also named G-protein-coupled estrogen receptor, shows beneficial effect on female patients with heart failure. This research aimed to probe the role and mechanism of GPR30 in myocardial hypertrophy. The model of cardiac hypertrophy was induced by infusion of angiotensin (Ang) II in mice, and was induced by Ang II treatment in neonatal rat cardiomyocyte (NRCM). The mouse model of myocardial hypertrophy was induced by angiotensin (Ang) Ⅱ, and the neonatal rat cardiomyocyte (NRCM) was induced by Ang Ⅱ treatment. GPR30 agonist G1 reduced cardiac hypertrophy induced by Ang II in mice, and reduced cardiac atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and β-myosin heavy chain (β-MHC) induced by Ang II. Ang Ⅱ treatment of myocardial fibrosis in mice was suppressed after administration of G1. GPR30 deficiency produced the opposite results. Oxidative stress and apoptosis were enhanced in the mice heart induced by Ang II, which were suppressed by G1 administration, but were further exacerbated after GPR30 deficiency. The outcomes demonstrated that GPR30 participated in the regulation of cardiac hypertrophy and fibrosis. Activation of GPR30 ameliorated cardiac hypertrophy and fibrosis by reducing oxidative stress and apoptosis.

摘要

G 蛋白偶联受体(GPCRs)是介导心脏疾病效应的最大的一类膜受体,GPR30 也被称为 G 蛋白偶联雌激素受体,对心力衰竭的女性患者有有益作用。本研究旨在探讨 GPR30 在心肌肥厚中的作用和机制。心肌肥厚模型通过在小鼠中输注血管紧张素(Ang)II 诱导,通过 Ang II 处理新生大鼠心肌细胞(NRCM)诱导。心肌肥厚的小鼠模型是通过血管紧张素(Ang)Ⅱ诱导的,新生大鼠心肌细胞(NRCM)是通过 Ang Ⅱ处理诱导的。GPR30 激动剂 G1 可减少 Ang II 诱导的小鼠心肌肥厚,并减少 Ang II 诱导的心肌心房利钠肽(ANP)、脑利钠肽(BNP)和β-肌球蛋白重链(β-MHC)。G1 给药后可抑制 Ang II 处理的小鼠心肌纤维化。GPR30 缺失则产生相反的结果。Ang II 诱导的小鼠心脏氧化应激和细胞凋亡增强,G1 给药可抑制其作用,但 GPR30 缺失后进一步加重。这些结果表明,GPR30 参与了心脏肥大和纤维化的调节。激活 GPR30 可通过减少氧化应激和细胞凋亡来改善心肌肥厚和纤维化。

相似文献

1
G-protein coupled receptor 30 attenuates myocardial hypertrophy by reducing oxidative stress and apoptosis in Ang II-treated mice.G 蛋白偶联受体 30 通过减少血管紧张素 II 处理的小鼠中的氧化应激和细胞凋亡来减轻心肌肥厚。
Peptides. 2022 Nov;157:170878. doi: 10.1016/j.peptides.2022.170878. Epub 2022 Sep 13.
2
Targeting of midkine alleviates cardiac hypertrophy via attenuation of oxidative stress and autophagy.靶向中期因子可通过减轻氧化应激和自噬来缓解心肌肥厚。
Peptides. 2022 Jul;153:170800. doi: 10.1016/j.peptides.2022.170800. Epub 2022 Apr 12.
3
Pharmacological activation of estrogenic receptor G protein-coupled receptor 30 attenuates angiotensin II-induced atrial fibrosis in ovariectomized mice by modulating TGF-β1/smad pathway.雌激素受体 G 蛋白偶联受体 30 的药理学激活通过调节 TGF-β1/smad 通路减轻去卵巢小鼠血管紧张素 II 诱导的心房纤维化。
Mol Biol Rep. 2022 Jul;49(7):6341-6355. doi: 10.1007/s11033-022-07444-8. Epub 2022 May 5.
4
Vaspin Ameliorates Cardiac Remodeling by Suppressing Phosphoinositide 3-Kinase/Protein Kinase B Pathway to Improve Oxidative Stress in Heart Failure Rats.脂联素通过抑制磷酸肌醇 3-激酶/蛋白激酶 B 通路改善心力衰竭大鼠的氧化应激从而减轻心脏重构。
J Cardiovasc Pharmacol. 2022 Sep 1;80(3):442-452. doi: 10.1097/FJC.0000000000001291.
5
[Aconitine ameliorates cardiomyocyte hypertrophy induced by angiotensin Ⅱ].[乌头碱改善血管紧张素Ⅱ诱导的心肌细胞肥大]
Zhongguo Zhong Yao Za Zhi. 2019 Apr;44(8):1642-1647. doi: 10.19540/j.cnki.cjcmm.20190117.002.
6
Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy.肌细胞特异性增强因子 2C:miR-214-3p 抑制血管紧张素 II 诱导的心肌细胞肥大的新靶基因。
Sci Rep. 2016 Oct 31;6:36146. doi: 10.1038/srep36146.
7
G Protein-Coupled Estrogen Receptor 1 Inhibits Angiotensin II-Induced Cardiomyocyte Hypertrophy via the Regulation of PI3K-Akt-mTOR Signalling and Autophagy.G 蛋白偶联雌激素受体 1 通过调节 PI3K-Akt-mTOR 信号通路和自噬抑制血管紧张素 II 诱导的心肌细胞肥大。
Int J Biol Sci. 2019 Jan 6;15(1):81-92. doi: 10.7150/ijbs.28304. eCollection 2019.
8
Activation of GPR30 attenuates diastolic dysfunction and left ventricle remodelling in oophorectomized mRen2.Lewis rats.GPR30 的激活可减轻去卵巢 mRen2.Lewis 大鼠的舒张功能障碍和左心室重构。
Cardiovasc Res. 2012 Apr 1;94(1):96-104. doi: 10.1093/cvr/cvs090. Epub 2012 Feb 10.
9
Overexpression of miR-142-3p improves mitochondrial function in cardiac hypertrophy.miR-142-3p 的过表达改善心肌肥厚中的线粒体功能。
Biomed Pharmacother. 2018 Dec;108:1347-1356. doi: 10.1016/j.biopha.2018.09.146. Epub 2018 Oct 4.
10
Inhibition of farnesyl pyrophosphate synthase attenuates angiotensin II-induced cardiac hypertrophy and fibrosis in vivo.法呢基焦磷酸合酶抑制剂可减轻血管紧张素Ⅱ诱导的体内心肌肥厚和纤维化。
Int J Biochem Cell Biol. 2013 Mar;45(3):657-66. doi: 10.1016/j.biocel.2012.12.016. Epub 2012 Dec 29.

引用本文的文献

1
Hormone Replacement Therapy and Cardiovascular Health in Postmenopausal Women.绝经后女性的激素替代疗法与心血管健康
Int J Mol Sci. 2025 May 24;26(11):5078. doi: 10.3390/ijms26115078.
2
Targeting estrogen receptor signaling for treating heart failure.针对雌激素受体信号通路治疗心力衰竭。
Heart Fail Rev. 2024 Jan;29(1):125-131. doi: 10.1007/s10741-023-10356-9. Epub 2023 Oct 3.